Results 71 to 80 of about 1,546,198 (186)

Cystic fibrosis year in review 2023

open access: yesPediatric Pulmonology, Volume 59, Issue 12, Page 3106-3116, December 2024.
Abstract This past year, there were many important advances for patients with cystic fibrosis (CF). Of the many publications related to CF in 2023, there was further evaluation of highly effective modulator therapy, new assessments and guidelines for clinical manifestations and therapies for CF, advances in newborn screening and diagnosis, and ...
David V. Swetland, Adrienne P. Savant
wiley   +1 more source

Global Burden, Point Sources, and Outbreak Management of Healthcare-Associated Burkholderia Cepacia Infections: An Integrative Review

open access: yes, 2020
Objective: To examine the global burden, associated point sources, and successful prevention and control measures for documented outbreaks of Burkholderia cepacia healthcare-associated infections (HAIs). Design: Integrative review.
Russo, Philip L   +16 more
core   +1 more source

Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches

open access: yesFrontiers in Microbiology, 2017
Burkholderia cenocepacia is an opportunistic pathogen particularly dangerous for cystic fibrosis (CF) patients. It can cause a severe decline in CF lung function possibly developing into a life-threatening systemic infection known as cepacia syndrome ...
Viola C. Scoffone   +6 more
doaj   +1 more source

Cefiderocol utilization in lung transplant recipients at a single center

open access: yesTransplant Infectious Disease, Volume 26, Issue 4, August 2024.
A retrospective analysis of cefiderocol utilization in lung transplant recipients at a single center. This study highlights the primary indications, adverse effects, and mortality outcomes, among other measures, providing insight into its potential use in managing multidrug‐resistant infections in this population.
Purnadeo N. Persaud   +4 more
wiley   +1 more source

Surviving but stigmatised:Making sense of living with Burkholderia cepacia

open access: yes, 2012
Infection control policies recommend segregation of people with Cystic Fibrosis (CF) according to bacterial status. This involves isolating those people with cepacia from all other CF patients in order to prevent additional infection.
Smallman, Elaine   +2 more
core   +2 more sources

Update of the list of qualified presumption of safety (QPS) recommended microbiological agents intentionally added to food or feed as notified to EFSA 20: Suitability of taxonomic units notified to EFSA until March 2024

open access: yesEFSA Journal, Volume 22, Issue 7, July 2024.
Abstract The qualified presumption of safety (QPS) process was developed to provide a safety assessment approach for microorganisms intended for use in food or feed chains. In the period covered by this statement, no new information was found that would change the status of previously recommended QPS TUs. The TUs in the QPS list were updated based on a
EFSA Panel on Biological Hazards (BIOHAZ)   +27 more
wiley   +1 more source

ТРАНСПЛАНТАЦИЯ ЛЕГКИХ ПРИ МУКОВИСЦИДОЗЕ С ХРОНИЧЕСКИМ ИНФИЦИРОВАНИЕМ ДЫХАТЕЛЬНЫХ ПУТЕЙ BURKHOLDERIA CEPACIA (первое наблюдение в Российской Федерации) [PDF]

open access: yes, 2016
Cystic fibrosis (CF) is the third most common indication for lung transplantation. The recipients with CF have shown the best early and late survival rates after surgery.
M. M. Vodneva   +19 more
core   +1 more source

Potential mechanisms underlying the acute lung dysfunction and bacterial extrapulmonary dissemination during Burkholderia cenocepacia respiratory infection

open access: yesRespiratory Research, 2010
Background Burkholderia cenocepacia, an opportunistic pathogen that causes lung infections in cystic fibrosis (CF) patients, is associated with rapid and usually fatal lung deterioration due to necrotizing pneumonia and sepsis, a condition known as ...
Saliba Alessandra M   +7 more
doaj   +1 more source

91 Retrospective chart review of cases of cepacia syndrome (CS) in adults with cystic fibrosis (CF)

open access: yesJournal of Cystic Fibrosis, 2015
Objective To evaluate factors influencing the efficacy of provide treatment. Methods Retrospective chart review adult CF patients from July 2006 to December 2013. The patients were divided into two groups: response or non-response to treatment. BMI, severity of genotype, spirometry parameters, performed therapy, white blood cell count at admission ...
M. Usacheva, S. Krasovskiy, E. Amelina
openaire   +1 more source

Cystic Fibrosis and Primary Ciliary Dyskinesia Share Extensive Similarities: Is It Time to Place Them Under a Common Umbrella?

open access: yes
Pediatric Pulmonology, Volume 60, Issue 11, November 2025.
Andreas M. Matthaiou   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy